887 related articles for article (PubMed ID: 19029633)
21. Whole blood viscosity and arterial thrombotic events in patients with systemic lupus erythematosus.
Booth S; Chohan S; Curran JC; Karrison T; Schmitz A; Utset TO
Arthritis Rheum; 2007 Jun; 57(5):845-50. PubMed ID: 17530685
[TBL] [Abstract][Full Text] [Related]
22. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
23. [Prothrombotic state in early stages of chronic Chagas' disease. Its association with thrombotic risk factors].
Herrera RN; Díaz E; Pérez Aguilar R; Bianchi J; Berman S; Luciardi HL
Arch Cardiol Mex; 2005; 75 Suppl 3():S3-38-48. PubMed ID: 16366168
[TBL] [Abstract][Full Text] [Related]
24. Risk of thrombosis in patients with antiphospholipid antibodies and factor V Leiden mutation.
Pablos JL; Caliz RA; Carreira PE; Atsumi T; Serrano L; Amengual O; Santiago B; Khamashta MA; Hughes GR; Gomez-Reino JJ
J Rheumatol; 1999 Mar; 26(3):588-90. PubMed ID: 10090167
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Cervera R; Espinosa G; Carmona F; Balasch J; Ordinas A; Ingelmo M
Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121
[TBL] [Abstract][Full Text] [Related]
26. [Incidence of selected antiphospholipid antibodies in a group of patients with systemic lupus erythematosus].
Fojtík Z; Beránek M; Klabusay M; Korístek Z; Buliková A
Vnitr Lek; 2004 Apr; 50(4):267-73. PubMed ID: 15214295
[TBL] [Abstract][Full Text] [Related]
27. Thrombin generation measured ex vivo following microvascular injury is increased in SLE patients with antiphospholipid-protein antibodies.
Musiał J; Swadźba J; Jankowski M; Grzywacz M; Bazan-Socha S; Szczeklik A
Thromb Haemost; 1997 Oct; 78(4):1173-7. PubMed ID: 9364980
[TBL] [Abstract][Full Text] [Related]
28. Primary upper-extremity deep vein thrombosis: high prevalence of thrombophilic defects.
Hendler MF; Meschengieser SS; Blanco AN; Alberto MF; Salviú MJ; Gennari L; Lazzari MA
Am J Hematol; 2004 Aug; 76(4):330-7. PubMed ID: 15282664
[TBL] [Abstract][Full Text] [Related]
29. [Prevalence of thrombosis in secondary antiphospholipid-protein syndrome].
Swadźba J; Musiał J; Jankowski M; Grzywacz M; Szczeklik A
Pol Merkur Lekarski; 1996 Nov; 1(5):310-2. PubMed ID: 9273202
[TBL] [Abstract][Full Text] [Related]
30. Antiphospholipid antibodies, haemostatic variables and thrombosis--a survey of 144 patients.
Ames PR; Pyke S; Iannaccone L; Brancaccio V
Thromb Haemost; 1995 May; 73(5):768-73. PubMed ID: 7482401
[TBL] [Abstract][Full Text] [Related]
31. Antiphospholipid antibodies--our experience.
Srikrishna A; Sitalakshmi S; Devi S; Damodar P; Varghese J; Suresh J; Mathew T
Indian J Pathol Microbiol; 2004 Apr; 47(2):174-7. PubMed ID: 16295461
[TBL] [Abstract][Full Text] [Related]
32. Antithrombin, protein S and protein C and antiphospholipid antibodies in systemic lupus erythematosus.
Costallat LT; Ribeiro CC; Annichino-Bizzacchi JM
Sangre (Barc); 1998 Oct; 43(5):345-8. PubMed ID: 9868323
[TBL] [Abstract][Full Text] [Related]
33. [Comparative analysis of clinical and laboratory charactiristics of antiphospholipid syndrome].
Soltész P; Veres K; Kiss E; Lakos G; Sonkoly I; Muszbek L; Szegedi G
Orv Hetil; 2000 Dec; 141(52):2821-5. PubMed ID: 11202118
[TBL] [Abstract][Full Text] [Related]
34. Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies--a crucial role for acquired free protein S deficiency.
Ames PR; Tommasino C; Iannaccone L; Brillante M; Cimino R; Brancaccio V
Thromb Haemost; 1996 Aug; 76(2):190-4. PubMed ID: 8865529
[TBL] [Abstract][Full Text] [Related]
35. Thrombophilic risk factors in patients with cranial and spinal dural arteriovenous fistulae.
Gerlach R; Boehm-Weigert M; Berkefeld J; Duis J; Raabe A; Seifert V; Marquardt G
Neurosurgery; 2008 Oct; 63(4):693-98; discussion 698-9. PubMed ID: 18824942
[TBL] [Abstract][Full Text] [Related]
36. [Thrombophilia in systemic lupus erythematosus: A case-control study].
Belfeki N; Khanfir MS; Said F; Houman MH
J Med Vasc; 2018 Dec; 43(6):347-353. PubMed ID: 30522706
[TBL] [Abstract][Full Text] [Related]
37. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
Sarzi-Puttini P; Atzeni F; Carrabba M
Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154
[TBL] [Abstract][Full Text] [Related]
38. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus.
Nojima J; Iwatani Y; Suehisa E; Kuratsune H; Kanakura Y
Haematologica; 2006 May; 91(5):699-702. PubMed ID: 16627257
[TBL] [Abstract][Full Text] [Related]
39. [Association between antiphospholipid antibodies and arterial or venous thrombosis/thrombocytopenia].
Nojima J; Suehisa E; Kuratsune H; Amino N
Rinsho Byori; 1998 Dec; 46(12):1181-7. PubMed ID: 9916502
[TBL] [Abstract][Full Text] [Related]
40. Differences in protein S and C4b-binding protein levels in different groups of patients with antiphospholipid antibodies.
Forastiero RR; Kordich L; Basilotta E; Carreras LO
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):609-16. PubMed ID: 7841319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
